-
Galderma drug for common skin condition becomes available
FORT WORTH, Texas — A topical medication made by Galderma Labs for treating melasma of the face is now available in pharmacies, Galderma said.
Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%), tretinoin 0.05%) is described as the only Food and Drug Administration-approved triple combination topical product for the short-term treatment of moderate to severe melasma. The chronic skin condition affects more than 7 million people in the United States.
-
Type 1 diabetes spikes among Philadelphia children, study finds
PHILADELPHIA — While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.